Clinical Trials Browser

Phase 2 × Opportunistic Infections × 90 days × Clear all

Autoimmune Diseases, Immune System Diseases, Lymphoproliferative Disorders, Opportunistic Infections, Lymphoma, T-Cell, Peripheral